Herbal Extract Used for Colon Anticancer Activity: - A Systemic Review

The environmental, genetic, and dietary variables that contribute to colon cancer make it the third most frequent type of cancer. It is well-known that chemicals derived from plants can inhibit tumour growth, mitigate radiation and chemotherapy's negative effects, and regress colon cancer on a cellular level. There are numerous bioactive phytochemicals found in medicinal plants, including flavonoids, polyphenol compounds, catechins, caffeic acid, luteolin, kaempferol, luteolin glycosides, quercetin, among many others. These bioactive chemicals have multiple methods that can inhibit tumour cell proliferation, including activation of initiator and executioner caspase, which promotes apoptosis, and blocking of cell cycle checkpoints. In the fight against cancer, inflammation, mutagenesis, and angiogenesis, traditional medicines have long been used. When given in their active and pure forms, these medications also successfully block the progression of cancer in its early and middle stages. But conventional medicine has its detractors because of several big problems. There are a number of issues with these chemicals, such as their low solubility and absorption rates, medication synergism, lack of drug-likeness, and ambiguous extraction methods from plants. There are benefits and drawbacks to using bioactive substances in colon cancer treatment. This review focuses on the advantages and difficulties of treating colon cancer with bioactive compounds derived from plants. The use of these substances to target the self-renewal of cancer stem cells, as well as their bioavailability, safety precautions, and impact on cancer cell metabolism, have all been covered.